Gemmer Asset Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-62
Closed -$4K 547
2022
Q1
$4K Sell
62
-13
-17% -$702 ﹤0.01% 999
2021
Q4
$3K Buy
75
+26
+53% +$1.51K ﹤0.01% 1121
2021
Q3
$3K Buy
49
+6
+14% +$417 ﹤0.01% 1123
2021
Q2
$3K Hold
43
﹤0.01% 1296
2021
Q1
$3K Buy
43
+3
+8% +$236 ﹤0.01% 1264
2020
Q4
$3K Hold
40
﹤0.01% 1214
2020
Q3
$2K Buy
40
+7
+21% +$385 ﹤0.01% 1188
2020
Q2
$2K Sell
33
-40
-55% -$2.21K ﹤0.01% 1171
2020
Q1
$4K Buy
73
+21
+40% +$1.39K ﹤0.01% 842
2019
Q4
$4K Buy
52
+8
+18% +$499 ﹤0.01% 1036
2019
Q3
$3K Buy
44
+8
+22% +$531 ﹤0.01% 1146
2019
Q2
$2K Hold
36
﹤0.01% 1243
2019
Q1
$3K Hold
36
﹤0.01% 1172
2018
Q4
$2K Buy
+36
New +$2.9K ﹤0.01% 1215

Other funds holding HQY

Gemmer Asset Management's HQY Position: Q2 2022 in Review

Gemmer Asset Management sold out of HealthEquity (HQY) in Q2 2022, closing a stake of 62 shares — an estimated $4K sold.

Gemmer Asset Management first reported a position in HQY in Q4 2018 and held it in 14 quarters. The position peaked at $4K in Q1 2022. 307 funds tracked by Wall St. Rank hold HQY as of Q2 2022.

  • Gemmer Asset Management reported no remaining HealthEquity position as of Q2 2022 after selling out during the quarter.
  • Gemmer Asset Management sold 62 HealthEquity shares in Q2 2022, an estimated $4K.
  • Gemmer Asset Management first reported a position in HealthEquity in Q4 2018 and held it in 14 quarters.
  • Gemmer Asset Management's HealthEquity position peaked at $4K in Q1 2022.
  • 307 funds tracked by Wall St. Rank held HealthEquity as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.